Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial
KN026联合多西他赛治疗HER2阳性乳腺癌的疗效和安全性:一项II期临床试验
期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12662
Ma, Jianli; Wang, Jingxuan; Xu, Ting; Ouyang, Quchang; Wang, Xiaojia; Wang, Jingfen; Gan, Lu; Ouyang, Zhong; Lin, Daren; Sun, Tao; Shan, Changping; Yao, Herui; Zhang, Baochun; Li, Zhengguang; Zhuang, Zhixiang; Lu, Ying; Yang, Hongwei; Huang, Jian; Yang, Xingwang; Sun, Hongmei; Zhang, Qingyuan